⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAI News
Caris Life Sciences, Inc. Common Stock
CAI inicia una nueva etapa con la inversión de JLL Partners. USA - español APAC - English USA - English USA - English
prnewswire.com
CAI
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
prnewswire.com
CAI
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
prnewswire.com
CAI
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
prnewswire.com
CAI
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
prnewswire.com
CAI
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
prnewswire.com
CAI
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
prnewswire.com
CAI
CAI Named to Fortune’s America’s Most Innovative Companies 2026 List
globenewswire.com
CAI
CAI segna trent'anni di progresso nella prontezza operativa e nell'eccellenza nelle scienze della vita e nei settori critici
businesswire.com
CAI
CAI、ライフサイエンス業界とミッション・クリティカル業界で30年にわたりオペレーショナル・レディネスとオペレーショナル・エクセレンスを推進
businesswire.com
CAI